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There is an expanding interface between electronic engineering and neurosurgery. Rapid
advances in microelectronics and materials science, driven largely by consumer demand,
are inspiring and accelerating development of a new generation of diagnostic, therapeutic,
and prosthetic devices for implantation in the nervous system. This paper reviews some of
the basic science underpinning their development and outlines some opportunities and
challenges for their use in neurosurgery.
© 2016 The Author. Published by Elsevier Ltd on behalf of Royal College of Surgeons of
Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Introduction
Charles Babbage pioneered early mechanical computing de-
vices in the 1820s.1 Today's computers have a predominantly
microelectronic substrate and their performance, efficiency,
and affordability continue to improve rapidly and predict-
ably2,3 (see Fig. 1A). By the 1980s, this allowed development of
portable electronic devices. Now even smaller and more
energy-efficient microelectronic devices are enabling the
transition from portable to wearable to implantable. In tandem
with an improving understanding of neuroebiotic interfaces
and the computational machinery of the brain, such advances
are enabling new ways to invasively monitor, interact, and
intervene with nervous systems.ac.uk.
Elsevier Ltd on behalf of
in Ireland. This is an
).Micro-electromechanical systems (MEMS) combine mini-
aturized mechanical and electromechanical elements.4 Their
physical dimensions range from several millimetres to well
below one micron. The functional elements of MEMS are
shown in Fig. 1B. MEMS transduction components (micro-
sensors and microactuators) convert energy from one form to
another and have particular relevance in biomedical applica-
tions. Awide range ofmicrosensors now exist, including those
that measure temperature, pressure, magnetic fields, radia-
tion, impedance, inertial forces, and different chemical spe-
cies. Micro-actuators include tools capable of ablating tissue
(using heat, light, or ultrasound, for example) and tools for
controlled delivery of bioactive molecules (such as chemo-
therapy or neurotransmitters). Others includemicro-valves to
control fluid flow, optical switches to modulate or redirect
light, and micro-resonators.Royal College of Surgeons of Edinburgh (Scottish charity number
open access article under the CC BY-NC-ND license (http://
Fig. 1 e (a) Trends showing the rapid and persisting increase in computational power, and decrease in microchip size, in
recent decades (based on data from Refs. [2,3]). (b) The component parts of the archetypal micro-electromechanical system.
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for batch fabrication in the integrated circuit industry. Once
production reaches scale, this serves to lower production
costs and increase reliability and functionality. MEMS (and
their nano-scale equivalent, NEMS) enable the development of
complete systems-on-a-chip: sensors collect information that
is processed locally and used to direct actuators that alter
aspects of the surrounding environment. In an implanted
in vivo context, this model has numerous potential
applications.
Usefully, the nervous system itself is governed by elec-
tronic signals: ions in solution move through membrane-
bound channels in neurons, whilst electrons move within
the solid-state lattices of microelectronic semiconductors.
Hybridising the two systems to create a neuroebionic inter-
face is therefore a logical proposition, though one with mul-
tiple biological and engineering challenges. Beyond offering
new ways of monitoring and intervening, hybrid systems can
link neurons to prosthetic effectors; thereby offering a means
of restoring function by circumventing an area of nervous
system damage. This addresses the nervous system's very
restricted capacity to recover or reorganise, and may finally
allow neurosurgeons to mitigate primary brain injury. This
paper outlines some of the challenges and opportunities for
CNS-implanted MEMS.a This approximation is based on assumptions of 86 billion
neurons, connected via 7000 synapses per neuron, firing at an
average frequency of 20 Hz, resulting in 1.204  1016 firing events
per second. Moreover, this approximation fails to appreciate
other “calculations” attributable to glia:neuron interactions or
neuropeptides, for example.Challenges
The CNS is an unforgiving environment in which to intervene
at all, let alone implant electrical devices. Complex neuro-
anatomy on a relatively small scale, notable vascularity, andconspicuous fragility are all challenges to implantation.
Beyond these pragmatic surgical considerations, a funda-
mental challenge for all bionic systems is the interface be-
tween living tissue and implanted material.5 The host
response to implantation of a foreign body tends to result in
encapsulation. In the brain this takes the form of gliosis,
resulting in insulation of the electrode or implanted compo-
nent.6 Ideally, implanted systems would induce minimal
foreign body response, allowing an intimate, long-term
interaction with specific cells (or even subcellular compo-
nents). These challenges have spurned extensive materials
science and electrical engineering research that aims to en-
gineer a sympathetic interaction and long-term functional
connection between neurons and microelectronic systems.
For neuro-prosthetic devices, there is also the pre-requisite
to interface with the computational apparatus of the brain. This
is a massive challenge. The human brain contains ~86 billion
neurons, each with ~7000 synapses, cooperatively performing
~12  1015 computations per second.a Different neurotrans-
mitter types, the variable influence of glial cells, and a dy-
namic ultrastructure complicates the situation further.
Moreover, neuronal organisation and connectivity evolve
during development, ageing, and in response to pathology.
Whilst electronic signalling is central to both domains,
there remain fundamental differences in computational
t h e s u r g e on 1 4 ( 2 0 1 6 ) 2 1 3e2 1 8 215strategy.7 Most microelectronic platforms operate in a
sequential, rigid, and fault intolerant mode. In contrast, ner-
vous systems comprise dynamic interconnected neuronswith
an intrinsic fault tolerance (see Fig. 2).
Beyond these biological and engineering issues, there are
ethical considerations when intervening with the brain. Its
complexity, coupled with its significance in human existence,
demands strong justifications for interventions of this sort.
Maintaining autonomy and protecting privacy is key, and
relate directly to maintaining trust during development and
deployment of novel neurotechnologies.8Experimental approaches to interaction
Intra-cortical implantation of electrodes, or any MEMS
component, is highly invasive. There is inevitable paren-
chymal damage together with risk of bleeding, infection or
seizure. Foreign bodies induce activation and migration of
microglia and astrocytes. Reactive gliosis around electrodes
impedes electrical conduction, as well as causing some local
neuronal cell death. Improving our understanding of the
abiotic:biotic interface is key. Much of the basic science work
in this area involves efforts to hybridisemicroelectronics with
simple neuronal networks in vitro; a pragmatic environment in
which to hone technologies. One of the core challenges is to
engineer a long-term sympathetic connection between the
key processing components of neurons (ion channels) and
those of electronics (electrodes and transistors). Several
groups approach this challenge by trying to gain topographic
control of the neuron or neurite (in an environment promoting
long-term survival) and using this to guide its engagement
with electrodes.9e14
Techniques tested in vitro include the use of microcontact
printing, where a microscopic stamp is used to print pro-
adhesive proteins (such as vitronectin or fibronectin) onto a
given surface (often silicon wafers) to define specific cell
adhesion.15 Similarly, inkjet printers have been used to
pattern pro-adhesive substances onto otherwise cytophobic
backgrounds.16 This method has enabled rat hippocampal
neurons and glia to be patterned successfully. Modifying
surface roughness or other topographic characteristics can
also be used to inform neuronal adhesion.17 Some of these
techniques lend themselves to use with multi-electrodeFig. 2 e A comparison between the components and modi oper
(reproduced from Ref. [7]).arrays (MEAs). For example, Marconi et al. aligned micro-
contact printing (using a silicon master) with a multi-channel
MEA, to both control location of hippocampal neurons and
also record electrophysiological characteristics.18 Similarly,
Boehler et al. aligned a polymeric silicon-based stamp (‘inked’
with polylysine) with a MEA-incorporated substrate.19 The
underlying electrodes recorded spike activity from specific
parts of the neuronal network.
Beyond interfacing with specific neuronal components,
better strategies are needed to maintain a long-term and
reliable contact between the lipid bilayer of the polarised
neuron and the oxide layer of silicon. Key variables are
resistance and distance. Novel electrode designs are one way
of improving andmaintaining this contact. Carbon nanotubes
(CNTs) are electrically conducting and have excellent inter-
facial electrical impedance.20 Sorkin et al. has cultured neu-
rons on 20 mm CNT islands on a background of quartz.21
Neurons entwine and anchor themselves to these CNT
islands, promoting a high fidelity electrical interface. Another
approach involves altering the nature of the electrode:neuron
interface by delivering bioactive molecules during or after
implantation. For example, neurotrophic factors (to facilitate
neurite outgrowth and neural preservation) or anti-
inflammatory drugs can be delivered adjacent to the elec-
trode or implanted device.22,23 These technologies all build
towards sympathetic, minimally disruptive, high channel,
sub-cellular resolution MEMS implantation tools.Clinical applications and opportunities
Implanted electronic systems are already well-established in
some neurosurgical settings (e.g. deep brain stimulation and
vagus nerve stimulation) and deployed experimentally in
others (e.g. invasive neuroprosthetic devices). As relevant
technology matures, applications are expanding.Sensors
Multi-modality sensors of intracranial pressure, temperature
and brain oxygen saturation are established tools in well-
resourced neuro-intensive care units. Most commonly a sin-
gle, temporary, wired transducer array is placed via burr-hole,andi of nervous systems and silicon-based computers
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parameters such as cerebral perfusion pressure and brain
oxygenation, and to guide the need for interval CT scan or
surgical intervention. These devices have changed very little
in recent decades and use old technology. Next generation
MEMS sensors have the potential to hugely expand this
approach. For example, Kang et al. have recently developed a
miniaturised bio-resorbable nano-porous silicon sensor of
temperature and pressure with dimensions of just
1 mm  2 mm  0.08 mm24 (see Fig. 3). In vivo tests of intra-
cranial pressure in rat brain compared well with existing
techniques. Uniquely, the sensor itself dissolves over time
when exposed to biofluids (such as cerebrospinal fluid), leav-
ing only biocompatible end products. It is also amenable to
wireless transmission of information.
In the management of glioma, implanted sensor arrays
embedded in the resection cavity may enable early detection
of tumour recurrence, rather than via intervalMRI as occurs at
present. Such arrays could detect changes in tissue imped-
ance, hypoxia, pH, or temperature to characterise and identify
the hallmarks of tumour progression. Such early warning
systems would allow proactive rather than reactive deploy-
ment of secondary therapies, and might also help to differ-
entiate true tumour progression from radio-necrosis (a well-
described problem in neuro-oncology). Moreover, combining
the sensor array with a MEMS component capable of lesioning
adjacent tissue would allow immediate in situ treatment. A
locally deployed therapy (e.g. hyperthermia induced by pass-
ing a current between two electrodes, or ultrasound, or UV
light, or release of an aliquot of chemotherapy) may have a
better side-effect protocol than systemically administered
therapies whose tissue penetrance is also restricted by the
blood brain barrier.
MEMS-based sensors also have a role in improving the
management of hydrocephalus. The primary treatment for
hydrocephalus is still a cerebrospinal fluid shunt (usually
draining to the peritoneal cavity). Whilst life saving, shunts
have high failure rates and are fundamentally crude devices.
Whilst variable flow and variable pressure valves have been
developed, there is a need for systems capable of deliveringFig. 3 e Adapted from Ref. [24] (a) Schematic illustration of biod
silicon-nanomembrane strain-gauge. (b) Optical micrograph of
outer diameter of the hypodermic needle is 1 mm.more advanced control, feedback, and communication. A
‘smart shunt’ of this sort has been envisaged for decades.25
Reliable sensors in shunts could relay information about
shunt functionality, CSF pressures, and the presence of
infection. Similarly, MEMS sensors may have a role in the
management of degenerative spinal conditions. Sensors
measuring pressure or acceleratory forces may guide devel-
opment of intelligent implants, capable of ameliorating
against adjacent level disease or pull-out of pedicle screws, for
example. For all of these systems, where internal variables are
transduced in real or near real time, robust and secure sys-
tems are needed to communicate and integrate data. With
wireless transmission to internet-connected smartphones,
such sensors become part of the ‘internet of things’.Stimulators
Stimulation of the brain, spine, and peripheral nervous sys-
tem is a well-established aspect of contemporary ‘functional’
neurosurgery. Deep brain stimulation (DBS) has a good evi-
dence base in Parkinson's disease,26 essential tremor and
dystonia,27 and refractory chronic pain syndromes.28 Its use in
other contexts (e.g. refractory depression, obsessive compul-
sive disorder, epilepsy, eating disorders, addiction, cognitive
decline) is under investigation. Peripheral nervous system
stimulators (such as occipital and vagal nerve stimulators) are
also in routine clinical use.
Crucially, current devices are somewhat crude in their
interaction; stimulating relatively large regions of tissue
indiscriminately. In DBS for Parkinson's disease, for example,
this results in unwanted cognitive and emotional side effects.
In tandem with improved understanding of disease-specific
neural circuits, advanced MEMS devices offer means of stim-
ulating the nervous systemwithmore specificity and delicacy.
For example, early iterations of DBS hardware are nowmaking
way for smaller, more complex and more sophisticated elec-
trodes capable of better-targeted stimulation.29,30
The growing field of in vivo piezo-electric energy scav-
enging (whereby movement of body tissues is used toegradable pressure sensor. Inset shows location of the
the strain-gauge region. (c) Image of complete device. The
t h e s u r g e on 1 4 ( 2 0 1 6 ) 2 1 3e2 1 8 217generate electricity) also offers a route to meeting the long-
term energy requirements of implanted electrical devices,
without the need for batteries.31 As these opportunities pre-
sent themselves, so interest from industry also grows.32Invasive neuroprostheses
A neuroprosthesis creates a de novo connection between the
nervous system and the external world, mediated by an
intervening computer. By incorporating a prosthetic ‘effector’,
the new connection can enable a behaviour. Simple input
neuroprosthetic devices have existed for decades, most
notably the cochlear implant which uses electronics to
transduce sound and, in near real time, stimulate the cochlear
nerve. Pathology affecting any CNS component downstream
of cortex (or any CNS-innervated structure) is theoretically
amenable to this form of therapy. Electrical activity is recor-
ded from functioning cortical regions (e.g. motor cortex), then
decoded in near real time, and used to control the effector (e.g.
robotic arm). This allows an area of pathology (e.g. spinal cord
injury) to be circumvented and a functional interaction with
the outside world re-established. The extent to which a new
activity can deliver real world benefit depends upon both the
underlying pathology and the fidelity of the neuroprosthesis
itself. Current electrode grids used to record from cortex can
record and ‘translate’ only a small proportion of cortical ac-
tivity. As devices become smaller and interact at higher res-
olution, neuroprostheses will become higher fidelity. Current
prosthetic devices range from an electric wheelchair, to an
innervated robotic limb,33 to a synthetic exoskeleton, to an
artificial sphincter. However, the effector or prosthesis need
not necessarily interact with the tangibleworld. Rather, it may
exist in an online virtual world manifesting as an electronic
avatar. Human BCI control of an on-screen computer cursor
illustrates feasibility of this concept.34Conclusion
New therapeutic opportunities are arising due to advances in
both microelectronics and neurobiology. Translating these
advances into new therapies is challenging and will demand
innovative collaborations amongst engineers, biologists, sur-
geons, and industry.Conflicts of interest
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